activins has been researched along with repsox in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esebanmen, GE; Langridge, WHR | 1 |
| Huang, Q; Li, Q | 1 |
2 other study(ies) available for activins and repsox
| Article | Year |
|---|---|
Mechanism of chimeric vaccine stimulation of indoleamine 2,3-dioxygenase biosynthesis in human dendritic cells is independent of TGF-β signaling.
Topics: Activins; Animals; Cell Differentiation; Cholera Toxin; Cloning, Molecular; Dendritic Cells; Escherichia coli; Gene Expression Regulation; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Integrins; Mice; Monocytes; Primary Cell Culture; Proinsulin; Protein Serine-Threonine Kinases; Pyrazoles; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Recombinant Fusion Proteins; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2017 |
Single-cell qPCR demonstrates that Repsox treatment changes cell fate from endoderm to neuroectoderm and disrupts epithelial-mesenchymal transition.
Topics: Activins; Cell Lineage; Endoderm; Epithelial-Mesenchymal Transition; Humans; Neural Plate; Polymerase Chain Reaction; Primitive Streak; Pyrazoles; Pyridines; Signal Transduction; Single-Cell Analysis; Transforming Growth Factor beta | 2019 |